{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:58:19Z","timestamp":1784613499692,"version":"3.55.0"},"reference-count":16,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institute of Allergy"},{"name":"Infectious Diseases (NIAID)"},{"name":"National Institutes of Health (NIH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Rapid diagnosis is key to containing viral outbreaks. However, for the current monkeypox outbreak the major deterrent to rapid testing is the requirement for higher biocontainment of potentially infectious monkeypox virus specimens. The current CDC guidelines require the DNA extraction process before PCR amplification to be performed under biosafety level 3 unless vaccinated personnel are performing assays. This increases the turn-around time and makes certain laboratories insufficiently equipped to handle specimens from patients with suspected monkeypox infection. We investigated the ability of five commercially available lysis buffers and heat for inactivation of monkeypox virus. We also optimized the use of monkeypox virus in Hologic\u00ae Panther Specimen Lysis Buffer for detection of virus in the Panther Fusion\u00ae Open Access System using published generic and clade specific monkeypox virus primers and probes.<\/jats:p>","DOI":"10.3390\/v14102227","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T02:10:27Z","timestamp":1665540627000},"page":"2227","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Five Buffers for Inactivation of Monkeypox Virus and Feasibility of Virus Detection Using the Panther Fusion\u00ae Open Access System"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-472X","authenticated-orcid":false,"given":"Robert J.","family":"Fischer","sequence":"first","affiliation":[{"name":"Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Gallogly","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Schulz","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-6359","authenticated-orcid":false,"given":"Neeltje","family":"van Doremalen","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Munster","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.15585\/mmwr.mm7128e1","article-title":"Rapid Diagnostic Testing for Response to the Monkeypox Outbreak\u2014Laboratory Response Network, United States, May 17\u2013\u2013June 30, 2022","volume":"71","author":"Aden","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/JCM.00346-16","article-title":"Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests","volume":"54","author":"Rosenstierne","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113835","DOI":"10.1016\/j.jviromet.2020.113835","article-title":"Inactivation of foot-and-mouth disease virus A\/IRN\/8\/2015 with commercially available lysis buffers","volume":"278","author":"Wood","year":"2020","journal-title":"J. Virol. Methods"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jviromet.2017.09.020","article-title":"The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples","volume":"250","author":"Burton","year":"2017","journal-title":"J. Virol. Methods"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1128\/JCM.01449-15","article-title":"Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type","volume":"53","author":"Smither","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pastorino, B., Touret, F., Gilles, M., Luciani, L., de Lamballerie, X., and Charrel, R.N. (2020). Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples. Viruses, 12.","DOI":"10.1101\/2020.04.11.036855"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jviromet.2010.07.012","article-title":"Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA","volume":"169","author":"Li","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104204","DOI":"10.1016\/j.jcv.2019.104204","article-title":"Panther Fusion(R) Respiratory Virus Assays for the detection of influenza and other respiratory viruses","volume":"121","author":"Stellrecht","year":"2019","journal-title":"J. Clin. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3201\/eid2810.221191","article-title":"Human Monkeypox without Viral Prodrome or Sexual Exposure, California, USA, 2022","volume":"28","author":"Karan","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2200636","DOI":"10.2807\/1560-7917.ES.2022.27.35.2200636","article-title":"Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022","volume":"27","author":"Paran","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.15585\/mmwr.mm7136e1","article-title":"Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox\u2014United States, 2022","volume":"71","author":"Minhaj","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: A prospective observational cohort study","volume":"400","author":"Alemany","year":"2022","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7883\/yoken.JJID.2008.140","article-title":"Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: Differentiation of Congo Basin and West African MPXV strains","volume":"61","author":"Saijo","year":"2008","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/infdis\/jix401","article-title":"Ebola Virus Inactivation by Detergents Is Annulled in Serum","volume":"216","author":"Tintu","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jmv.1890230313","article-title":"Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine","volume":"23","author":"Lelie","year":"1987","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e0031421","DOI":"10.1128\/AEM.00314-21","article-title":"Heat-Treated Virus Inactivation Rate Depends Strongly on Treatment Procedure: Illustration with SARS-CoV-2","volume":"87","author":"Gamble","year":"2021","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2227\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:49:14Z","timestamp":1760143754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":16,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["v14102227"],"URL":"https:\/\/doi.org\/10.3390\/v14102227","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}